• Journal of Gastric Cancer
• /
• 제20권4호
• /
• pp.395-407
• /
• 2020

Purpose: A phase II study was conducted to evaluate the safety and efficacy of preoperative, intra-arterial perfusion of epirubicin, etoposide, and oxaliplatin combined with oral chemotherapy S-1 (SEEOX) for the treatment of type 4 gastric cancer. Materials and Methods: A single-center, single-arm phase II trial was conducted on 36 patients with histologically proven type 4 gastric cancer without distant peritoneal or organ metastasis. Patients received 3, 21-day courses of SEEOX preoperative chemotherapy. The primary endpoint was overall survival (OS) and the secondary outcomes assessed were chemotherapeutic response, radical resection rate, pathological regression, toxicities, postoperative morbidity, and mortality. Results: All patients were at an advanced stage of cancer (stage III or IV) and completed the entire course of treatment. Based on changes in tumor volume and peritoneal metastasis, the objective response rate was 55.6% (20/36; 95% confidence interval [CI], 38.5%-72.6%) and the disease control rate was 69.4% (25/36; 95% CI, 53.6%-85.3%). The radical resection rate was 75% (27/36; 95% CI, 60.1%-89.9%) and the proportion of R0 resections was 66.7% (21/36; 95% CI, 50.5%-82.8%). The pathological response rate was 33.3%, of which 13.9% showed complete pathological regression. The median survival was 27.1 months (95% CI, 22.24-31.97 months), and the 2-year OS was 48.5% (95% CI, 30.86%-66.1%). Conclusions: Preoperative SEEOX is a safe and effective treatment for type 4 gastric cancer. Based on these preliminary data, a phase III study will be conducted to confirm the superiority of this regimen over standard treatment.

• Journal of Gastric Cancer
• /
• 제22권4호
• /
• pp.408-417
• /
• 2022

Purpose: Treatment options are limited after the failure of first-and second-line treatments in patients with HER2⁺ metastatic gastric cancer (mGC). The present study aimed to explore the efficacy, safety, and prognostic factors of apatinib efficacy as a third-line therapy for patients with human epithelial growth factor receptor 2-positive (HER2⁺) mGC. Materials and Methods: A total of 59 HER2⁺ mGC patients who received apatinib as third-line therapy were retrospectively enrolled in this two-center, single-arm, cohort study; the clinical response, survival data, and adverse events were retrieved. Results: The median progression-free survival (PFS) was 5.2 months (95% confidence interval [CI], 3.9-6.5), and the median overall survival (OS) was 8.2 months (95% CI, 6.6-9.8) Furthermore, forward stepwise multivariate Cox regression analysis showed that a higher Eastern Cooperative Oncology Group performance status score and multiple metastases were independently correlated with decreased PFS and OS (both P<0.05). The main adverse events were leukopenia (45.8%), hypertension (44.1%), thrombocytopenia (39.0%), hand-foot syndrome (37.3%), and elevated transaminase (33.9%). Grade 3 adverse events mainly included hypertension (5.1%) and neutropenia (5.1%); grade 4 adverse events did not occur. Conclusions: Apatinib is efficient and well tolerated in patients with HER2⁺ mGC as a third-line treatment, suggesting that it may be a candidate of choice for these patients.

• Radiation Oncology Journal
• /
• 제31권3호
• /
• pp.147-154
• /
• 2013

Purpose: To evaluate the role of salvage radiotherapy (RT) for the treatment of regional lymph node recurrence (RLNR) after radical surgery in advanced gastric cancer. Materials and Methods: We retrospectively analyzed medical records of 26 patients who underwent salvage treatment after diagnosis of RLNR between 2006 and 2011. Patients with peritoneal seeding or distant metastasis were excluded. Eighteen patients received RT with or without chemotherapy and the other 8 did chemotherapy only without RT. A three-dimensional conformal RT was performed with median dose of 56 Gy (range, 44 to 60 Gy). Sixteen patients had fluoropyrimidine-based chemotherapy, 5 did taxane-based chemotherapy, and irinotecan was applied in 4. Results: With a median follow-up of 20 months (range, 5 to 57 months), median overall survival (OS) and progression-free survival (PFS) after diagnosis of RLNR were 29 months and 12 months in the entire patients, respectively. Radiotherapy (p = 0.007) and disease-free interval (p = 0.033) were statistically significant factors for OS in multivariate analysis. Median OS was 36 months in patients who received RT and 16 months in those who did not. Furthermore, delivery of RT (p < 0.001), complete remission after salvage treatment (p = 0.040) and performance status (p = 0.023) were associated with a significantly better PFS. Gastrointestinal toxicities from RT were mild in most patients. Conclusion: Salvage RT combined with systemic chemotherapy may be an effective treatment managing RLNR from advanced gastric cancer.

• Journal of Gastric Cancer
• /
• 제23권2호
• /
• pp.328-339
• /
• 2023

Purpose: This study aimed to evaluate the efficacy and safety of neoadjuvant programmed cell death-1 (PD-1) inhibitors plus apatinib and chemotherapy (PAC) in patients with locally advanced gastric cancer (LAGC). Materials and Methods: Seventy-three patients with resectable LAGC were enrolled and named the PAC group (n=39) or apatinib plus chemotherapy (AC) group (n=34) based on the treatment they chose. Neoadjuvant therapy was administered in a 21-day cycle for 3 consecutive cycles, after which surgery was performed. Results: The PAC group exhibited a higher objective response rate than the AC group (74.4% vs. 58.8%, P=0.159). Moreover, the PAC group showed a numerically better response profile than the AC group (P=0.081). Strikingly, progression-free survival (PFS) (P=0.019) and overall survival (OS) (P=0.049) were prolonged, whereas disease-free survival (DFS) tended to be longer in the PAC group than in the AC group (P=0.056). Briefly, the 3-year PFS, DFS, and OS rates were 76.1%, 76.1%, and 86.7% in the PAC group and 46.9%, 49.9%, and 70.3% in the AC group, respectively. Furthermore, PAC (vs. AC) treatment (hazard ratio=0.286, P=0.034) was independently associated with prolonged PFS in multivariate Cox regression analyses. The incidence of adverse events did not differ between the two groups (all P>0.05), where leukopenia, anemia, hypertension, and other adverse events were commonly observed in the PAC group. Conclusions: Neoadjuvant PAC therapy may achieve a preferable pathological response, delayed progression, and prolonged survival compared to AC therapy with a similar safety profile in patients with LAGC; however, further validation is warranted.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권2호
• /
• pp.691-694
• /
• 2013

Purpose: By carrying out a meta-analysis of randomized controlled trials that compared sorafenib or combined chemotherapy with placebo or combined chemotherapy, the effectiveness of sorafenib in hepatocellular carcinoma was evaluated in the present study, which also provided clinical practice guidelines of evidence-based-medicine. Methods: We reviewed PubMed citations concerning sorafenib treating hepatocellular carcinoma in randomized controlled trials from Jan 2000 to July 2012. All the literature was extracted by Cochrane systematic reviews and underwent meta-analysis with RewMan 5.0 software. Results: Finally, four papers documenting randomized controlled studies were included. Compared with controls, sorafenib was shown to significantly increase overall survival (OS), time to progression (TTP), and disease control rates (DCR), but not the time to symptom progression (TTSP) in hepatocellular carcinoma patients. The incidence of grade-III/IV adverse reactions, including hand-foot-skin reactions, diarrhea, hypertension and skin rash or desquamation, in sorafenib treatment group was higher than that in controls. However, there was no significant difference in the incidence of hypodynamia between the two groups. Conclusions: Sorafenib exerts significant curative effects in hepatocellular carcinoma.

• 전기전자학회논문지
• /
• 제2권2호
• /
• pp.270-277
• /
• 1998

네트워크 발전으로 인하여 제어시스템은 집중화에서 분산화 된 아키텍춰를 지향하고 있다. 그러나 이러한 제어시스템은 범용 운용 시스템을 기반으로 설계되어 공정처리에서 요구되는 실시간 성을 보장하기는 미흡한 점이 많아 플랜트의 제어설비로서 실시간 운영체제를 탑재한 제어시스템이 점차로 증가하고 있다. 본 논문에서는 분산제어 시스템의 기능을 위해 운영체제는 실시간 성을 보장하는 조건을 만족하도록 실시간 처리 능력, 실시간 응답의 신뢰성 및 멀티 프로세스의 기능구현에 중점을 두었으며, 이 운영체제의 바탕 위에 주요 공정처리의 기능인 루프, 로직의 가능한 처리 수를 분석하고, 이의 타당성을 검토하였다. 그리고 온라인 시 처리중인 데이터에 영향을 미치지 않는 시스템을 설계하고, 절체에 소비되는 시간을 측정 하였다.

• 한국정밀공학회:학술대회논문집
• /
• 한국정밀공학회 2000년도 추계학술대회 논문집
• /
• pp.678-682
• /
• 2000

The purpose of this study is to develop a powerful 6-axes general welding robot utilizing a low cost vision system. The developed vision system is composed of a CCD camera, a PC with windows 98 OS, and a PC-Robot communication program using Visual C++. A test was carried out to investigate whether the welding torch can precisely follow up the welding path. It shows that the result of this study can readily be applied to practical welding operations.

• 대한전기학회:학술대회논문집
• /
• 대한전기학회 2003년도 학술회의 논문집 정보 및 제어부문 B
• /
• pp.653-656
• /
• 2003

We have designed embedded web sewer system and ported Linux operating system version 2.4.5 at our system. And then We implemented to control and monitor widely separated hardware and implemented to monitor widely separated image using CMOS image sensor HV7131B. Web server is the Boa web server with General Public License. We designed for this system using of Intel's SA1110 ARM core base processor and connecting input and output device at GPIO port of SA1110. Device driver of General purpose I/O for Embedded Linux OS is designed. And then the application program controlling driver is implemented to use of common gate interface C language. User is available to control and monitor at client PC. This method have benefit to reduce the Expenditure of hardware design and development time against PC base system and have various and capacious application against firmware base system.

• 한국콘텐츠학회:학술대회논문집
• /
• 한국콘텐츠학회 2009년도 춘계 종합학술대회 논문집
• /
• pp.845-850
• /
• 2009

분산 환경에서 이기종 시스템 간의 독립적이고 표준화된 환경을 지원하기 위해 RT-CORBA(Real-Time Common Object Request Broker Architecture) 기반의 오픈소스 TAO(The ACE ORB) 통신 미들웨어에 대한 연구가 활발해지고 있다. 실시간성 측면에서 TAO는 Windows나 Linux와 같은 범용 운영체제에서는 실시간성을 지원하지 않으며, VxWorks, LynxOS 등과 같은 실시간 운영체제에 의존하여 실시간성을 지원한다. 이에 본 논문에서는 실시간 운영체제인 VxWorks에 TAO 통신 미들웨어를 이식함으로써 TAO가 쓰레드 레벨의 실시간성을 지원할 수 있는 환경을 구축한다. 또한 TAO를 탑재한 범용 운영체제 Windows 및 Linux와의 통신을 통해 VxWorks로의 TAO 이식을 검증한다.

• 대한간호
• /
• 제31권5호
• /
• pp.29-38
• /
• 1992

The purpose of this is to find the anxiety score of OHS pt's family and general surgery pt's family and to offer basic data. The subjects of this study were 80 : 40 were OHS pt's family in Seoul Hospital and remaining 40 were OS pt's family in Capital Hospital. The data was collected between March 1, through May 30, 1992. The instruments used for this study were Zung's The Self-Rating Anxiety Scale. The collected daLa were analyzed using percentage, descriptive statistics, $X^2-test$, t-test and Two-way Anova. The finding's were as followed: 1. Test of hypothesis "The anxiety score of the Ol-lS pt's family were similar to as pt's family" was rejected (L=0.772 P>.05) 2. The mean score of anxiety of the OHS pt's family was 1.772, The mean score of anxiety of the OS pt's family was 1,790. 3. The relationship between anxiety of the OHS pt's family and GS pt's family and family's age was significant (P<.Ol) and the relationship between anxiety and age interaction effect. (F=242.0 P<.01) In conclusion, the anxiety score of the OI-IS pt's finding and GS pt's family was all high.